49-20-419. Coverage of exome sequence testing.
112 words·~1 min read·
/ut/title-49/chapter-20/49-20-419A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Effective 5/14/2019
49-20-419. Coverage of exome sequence testing.
(1)As used in this section, "exome sequence testing" means a genomic technique for sequencing the genome of an individual for diagnostic purposes.
(2)Beginning July 1, 2019, the program shall provide coverage for exome sequence testing:
(a)for a covered individual within the state risk pool who:
(i)is younger than 21 years of age; and
(ii)who remains undiagnosed after exhausting all other appropriate diagnostic-related tests;
(b)performed by a nationally recognized provider with significant experience in exome sequence testing;
(c)that is medically necessary; and
(d)at a rate set by the program.
Enacted by Chapter 320 , 2019 General Session